mcIRBP-9 is an orally bioavailable NF-kappaB inhibitor. mcIRBP-9 reduces the levels of TNF-alpha, IL-1beta and TGF-beta1 in renal tissues, and decreases LPS-induced IL-1beta production. mcIRBP-9 can be used in research related to diabetic nephropathy and type 2 diabetes mellitus[1].
Molecular Weight:
923.11
CAS Number:
[1489241-80-6]
Formula:
C42H74N12O11
Target:
NF-kappaB
Application Notes:
MCE Product type: Peptides
* VAT and and shipping costs not included. Errors and price changes excepted